Current and emerging pharmacotherapies for hereditary hemorrhagic telangiectasia
Sign Up to like & getrecommendations! Published in 2017 at "Expert Opinion on Orphan Drugs"
DOI: 10.1080/21678707.2017.1353417
Abstract: ABSTRACT Introduction: Hereditary Haemorrhagic Telangiectasia (HHT) or Rendu-Osler- Weber syndrome, is a multisystemic vascular rare disease characterized by localized angiodysplasia. It is an inherited autosomal dominant disease. The estimated prevalence is around 1 in 5,000.… read more here.
Keywords: hereditary hemorrhagic; current emerging; telangiectasia; pharmacotherapies hereditary ... See more keywords